highly significantp < 0·0001
The rise in seroprevalence between 2023 and 2025 was highly significant across sexes, regions, and provinces (p < 0·0001; Table 2 ).
The rise in seroprevalence between 2023 and 2025 was highly significant across sexes, regions, and provinces (p < 0·0001; Table 2 ).